Laparoscopic sleeve gastrectomy is one of the most recent advances in the surgical treatment of morbid obesity. Extended follow-up studies of large cohorts are needed to establish the usefulness of the operation. The objectives of this study are to delineate the role of sleeve gastrectomy in weight loss and in comorbidities among obese patients.
Patients who underwent laparoscopic sleeve gastrectomy in a single bariatric center were followed up for a 3-year period. Weight loss and status of several comorbidities were assessed at the 1st, 3rd, 6th, 12th, 18th, 24th, and 36th postoperative month.
Overall, after 3 years of follow-up of 88 patients, the mean body mass index (BMI) of the patients was 29.8 kg/m2 (SD ±6.1), the % total weight loss was 38.1 % (SD ±12.9), the % excess weight loss was 69.5 % (SD ±17.5), and the % estimated BMI loss was 81.4 % (SD ±22.3). These parameters changed significantly over the first year of follow-up (p < 0.001) and subsequently stabilized. The percentages of patients with hypertension (33.3 %), hyperlipidemia (26.4 %), diabetes mellitus (20.7 %), obstructive sleep apnea (20.2 %), and gastroesophageal reflux disease (GERD-27 %) were significantly reduced (10.5, 9.2, 1.1, 1.1, and 9.2 % respectively at 36 months postoperation), while 10 new cases of GERD appeared postoperatively. However, only three of the new GERD cases required medication, and only one of them experienced symptoms that persisted after the 3-year period.
Three years of close follow-up of patients who had undergone laparoscopic sleeve gastrectomy demonstrated satisfactory weight loss results. Promising results were also obtained regarding various comorbidities of obese patients. Longer follow-up studies for more patients are needed to delineate the exact role of sleeve gastrectomy on postoperative outcomes.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super–super obese patient. Obes Surg 13(6):861–864
Deitel M, Crosby RD, Gagner M (2008) The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg 18(5):487–496. doi:10.1007/s11695-008-9471-5
Sarela AI, Dexter SP, O’Kane M, Menon A, McMahon MJ (2012) Long-term follow-up after laparoscopic sleeve gastrectomy: 8–9-year results. Surg Obes Relat Dis 8(6):679–684. doi:10.1016/j.soard.2011.06.020
D’Hondt M, Vanneste S, Pottel H, Devriendt D, Van Rooy F, Vansteenkiste F (2011) Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc 25(8):2498–2504. doi:10.1007/s00464-011-1572-x
Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252(2):319–324. doi:10.1097/SLA.0b013e3181e90b31
Gumbs AA, Gagner M, Dakin G, Pomp A (2007) Sleeve gastrectomy for morbid obesity. Obes Surg 17(7):962–969
Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401–407
Cottam D, Qureshi FG, Mattar SG et al (2006) Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 20(6):859–863 Epub 2006 Apr 22
Sieber P, Gass M, Kern B, Peters T, Slawik M, Peterli R (2013) Five-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. doi:10.1016/j.soard.2013.06.024
Shi X, Karmali S, Sharma AM, Birch DW (2010) A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg 20(8):1171–1177. doi:10.1007/s11695-010-0145-8
Brethauer SA, Hammel JP, Schauer PR (2009) Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis 5(4):469–475. doi:10.1016/j.soard.2009.05.011
Fuks D, Verhaeghe P, Brehant O et al (2009) Results of laparoscopic sleeve gastrectomy: a prospective study in 135 patients with morbid obesity. Surgery 145(1):106–113. doi:10.1016/j.surg.2008.07.013
Albanopoulos K, Tsamis D, Leandros E (2013) Gastrobronchial fistula as a late complication of sleeve gastrectomy. Surg Obes Relat Dis 9(6):e97–e99
Han SM, Kim WW, Oh JH (2005) Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg 15:1469–1475
Uglioni B, Wolnerhanssen B, Peters T, Christoffel-Courtin C, Kern B, Peterli R (2009) Midterm results of primary vs. secondary laparoscopic sleeve gastrectomy (LSG) as an isolated operation. Obes Surg 19:401–406
Gagner M, Gumbs AA, Milone L, Yung E, Goldenberg L, Pomp A (2008) Laparoscopic sleeve gastrectomy for the super–super-obese (body mass index > 60 kg/m2). Surg Today 38:399–403
Himpens J, Dapri G, Cadiere GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456
Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319–324
Bohdjalian A, Langer FB, Shakeri-Leidenmühler S et al (2010) Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 20:535–540
Silecchia G, Boru C, Pecchia A et al (2006) Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg 16(9):1138–1144
Peterli R, Steinert RE, Woelnerhanssen B et al (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 22:740–748
Jiménez A, Casamitjana R, Flores L et al (2012) Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg 256:1023–1029
Schauer PR, Kashyap SR, Wolski K et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366:1567–1576
Vidal J, Ibarzabal A, Romero F et al (2008) Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18:1077–1082
Fritscher LG, Mottin CC, Canani S, Chatkin JM (2007) Obesity and obstructive sleep apnea–hypopnea syndrome: the impact of bariatric surgery. Obes Surg 17(1):95–99
Sarkhosh K, Switzer NJ, El-Hadi M, Birch DW, Shi X, Karmali S (2013) The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg 23(3):414–423. doi:10.1007/s11695-012-0862-2
Rawlins L, Rawlins MP, Brown CC, Schumacher DL (2013) Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis 9(1):21–25. doi:10.1016/j.soard.2012.08.014
Yu J, Zhou X, Li L, Li S, Tan J, Li Y, Sun X (2015) The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence. Obes Surg 25(1):143–158. doi:10.1007/s11695-014-1460-2
Konstantinos Albanopoulos, Dimitrios Tsamis, Maria Natoudi, Leonidas Alevizos, Georgios Zografos, Emmanouil Leandros have no conflicts of interest or financial ties to disclose.
About this article
Cite this article
Albanopoulos, K., Tsamis, D., Natoudi, M. et al. The impact of laparoscopic sleeve gastrectomy on weight loss and obesity-associated comorbidities: the results of 3 years of follow-up. Surg Endosc 30, 699–705 (2016). https://doi.org/10.1007/s00464-015-4262-2
- Sleeve gastrectomy
- Diabetes mellitus
- Sleep apnea
- Gastroesophageal reflux disease